Astoria Portfolio Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-604
Closed -$219K 311
2025
Q3
$219K Sell
604
-365
-38% -$114K 0.06% 246
2025
Q2
$272K Buy
969
+48
+5% +$19.3K 0.08% 200
2025
Q1
$393K Sell
921
-245
-21% -$98.4K 0.13% 141
2024
Q4
$459K Buy
1,166
+5
+0.4% +$2.09K 0.16% 116
2024
Q3
$583K Buy
1,161
+271
+30% +$145K 0.2% 86
2024
Q2
$482K Buy
890
+103
+13% +$54.4K 0.17% 90
2024
Q1
$393K Sell
787
-37
-4% -$18.4K 0.15% 100
2023
Q4
$407K Buy
824
+27
+3% +$12.5K 0.17% 95
2023
Q3
$358K Sell
797
-45
-5% -$20.4K 0.17% 108
2023
Q2
$352K Buy
842
+114
+16% +$52.6K 0.14% 129
2023
Q1
$346K Buy
+728
New +$346K 0.15% 128

Other funds holding ELV

Astoria Portfolio Advisors's ELV Position: Q4 2025 in Review

Astoria Portfolio Advisors sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 604 shares — an estimated $219K sold.

Astoria Portfolio Advisors first reported a position in ELV in Q1 2023 and held it in 11 quarters. The position peaked at $583K in Q3 2024. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Astoria Portfolio Advisors reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Astoria Portfolio Advisors sold 604 Elevance Health shares in Q4 2025, an estimated $219K.
  • Astoria Portfolio Advisors first reported a position in Elevance Health in Q1 2023 and held it in 11 quarters.
  • Astoria Portfolio Advisors's Elevance Health position peaked at $583K in Q3 2024.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Astoria Portfolio Advisors's 13F filing for Q4 2025, filed 24 Feb 2026.